Frontier tech, by field

17 technologies · 521 events

Companies in frontier tech

22 of 403 companies

StartupUSSep 16, 2026

Loyal

Veterinary drug company developing FDA-approved lifespan extension drugs for dogs.

Longevity biotechloyal.com
Public companyHKSep 7, 2026

Insilico Medicine

Generative AI drug discovery company that tests candidates such as rentosertib against aging clocks.

Longevity biotechinsilico.com
StartupUSJun 9, 2026

Life Biosciences

Develops partial epigenetic reprogramming therapies using OSK factors, led by ER-100 for optic neuropathies.

Longevity biotechlifebiosciences.com
Large companyUSMay 21, 2026

Calico Life Sciences

Alphabet-founded company researching the biology of aging and developing drugs for age-related diseases.

Longevity biotechcalicolabs.com
StartupUSMay 21, 2026

Nexo Therapeutics

Covalent small molecule discovery company working with Calico on targets for age-related diseases.

Longevity biotechnexotx.com
Public companyUSDec 4, 2025

BioAge Labs

Uses human aging biology to develop cardiometabolic drugs, including the NLRP3 inhibitor BGE-102.

Longevity biotechbioagelabs.com
Public companyUSNov 12, 2025

AbbVie

Partnered with Calico on aging drug research for over a decade before ending the alliance in 2025.

Longevity biotech, Nanotechnologyabbvie.com
Public companyUSSep 18, 2025

Unity Biotechnology

Developed senolytic drugs such as UBX1325 for eye disease; stockholders approved its dissolution in 2025.

Longevity biotechunitybiotechnology.com
StartupUSAug 14, 2025

Altos Labs

Research company working on cellular rejuvenation programming to reverse disease.

Longevity biotechaltoslabs.com
Public companyCNJun 26, 2025

Mabwell Bioscience

Developed the IL-11 antibody 9MW3811, explored for age-related diseases and licensed to Calico.

Longevity biotechmabwell.com
StartupGBJun 9, 2025

Shift Bioscience

Uses an AI virtual cell platform and aging clocks to find single-gene targets for safer cell rejuvenation.

Longevity biotechshiftbioscience.com
StartupUS

Cambrian Bio

Clinical-stage company developing drugs that target metabolic pathways that decline with age, such as AMPK and mTOR.

Longevity biotechcambrianbio.com
StartupGB

clock.health

Formerly clock.bio; builds science and tools to measure and rejuvenate human cells and tissues.

Longevity biotechclock.health
Public companyUS

Eli Lilly

Invested in NewLimit's 2025 extension round through Eli Lilly and Company.

Longevity biotechlilly.com
StartupUS

Gordian Biotechnology

Uses an in vivo drug discovery platform to find targets and therapies for complex age-related diseases.

Longevity biotechgordian.bio
NonprofitSA

Hevolution Foundation

Funds research, grants and company investments to extend healthy human lifespan.

Longevity biotechhevolution.com
StartupUS

Junevity

Develops siRNA therapeutics that reset gene networks to reverse disease.

Longevity biotechjunevity.com
StartupIM

Juvenescence

Develops medicines that target core aging mechanisms to treat and prevent age-related diseases.

Longevity biotechjuvlabs.com
StartupUS

NewLimit

Develops epigenetic reprogramming medicines to restore youthful function in old cells, starting with the liver.

Longevity biotechnewlimit.com
StartupUS

Rejuvenate Bio

Develops gene therapies for chronic age-related disease in companion animals and humans.

Longevity biotechrejuvenatebio.com
StartupUS

Retro Biosciences

Develops autophagy drugs, iPSC-derived cell therapies and tissue reprogramming aimed at adding ten healthy years.

Longevity biotechretro.bio
StartupUS

Rubedo Life Sciences

Develops drugs that target senescent cells, led by the topical GPX4 modulator RLS-1496.

Longevity biotechrubedolife.com